JP2012519724A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012519724A5 JP2012519724A5 JP2011553432A JP2011553432A JP2012519724A5 JP 2012519724 A5 JP2012519724 A5 JP 2012519724A5 JP 2011553432 A JP2011553432 A JP 2011553432A JP 2011553432 A JP2011553432 A JP 2011553432A JP 2012519724 A5 JP2012519724 A5 JP 2012519724A5
- Authority
- JP
- Japan
- Prior art keywords
- ctb
- hapten
- subunit
- inducing
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000009016 Cholera Toxin Human genes 0.000 claims 2
- 108010049048 Cholera Toxin Proteins 0.000 claims 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 1
- 238000001467 acupuncture Methods 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 210000004900 c-terminal fragment Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20962909P | 2009-03-09 | 2009-03-09 | |
| US61/209,629 | 2009-03-09 | ||
| PCT/EP2010/052997 WO2010103017A2 (en) | 2009-03-09 | 2010-03-09 | Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012519724A JP2012519724A (ja) | 2012-08-30 |
| JP2012519724A5 true JP2012519724A5 (enExample) | 2013-04-25 |
Family
ID=42555592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011553432A Pending JP2012519724A (ja) | 2009-03-09 | 2010-03-09 | シグナルペプチドを担体として有する細菌毒素とのハプテン‐担体抱合体及び免疫原性組成物としてのその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20120100171A1 (enExample) |
| EP (1) | EP2405943A2 (enExample) |
| JP (1) | JP2012519724A (enExample) |
| KR (1) | KR20120022760A (enExample) |
| CN (1) | CN102427828A (enExample) |
| CA (1) | CA2754592A1 (enExample) |
| MX (1) | MX2011009359A (enExample) |
| RU (1) | RU2011140858A (enExample) |
| WO (1) | WO2010103017A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2355846A4 (en) * | 2008-09-03 | 2013-06-19 | Univ Michigan State | IMMUNOGENIC HEAT STABILIZER ESCHERICHIA COLI-ENTEROTOXIN |
| AU2010249330B2 (en) | 2009-05-22 | 2015-11-05 | Genocea Biosciences Inc. | Vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response |
| WO2011041483A2 (en) * | 2009-09-30 | 2011-04-07 | Toxcure, Inc. | Use of botulinum neurotoxin to treat substance addictions |
| AU2011336894B2 (en) | 2010-11-24 | 2016-11-17 | Genocea Biosciences, Inc. | Vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response |
| WO2012125720A2 (en) | 2011-03-14 | 2012-09-20 | University Of Louisville Research Foundation, Inc. | Polypeptides having immunoactivating activity and methods of producing the same |
| WO2017004168A1 (en) | 2015-06-29 | 2017-01-05 | University Of Louisville Research Foundation, Inc. | Compositions and methods for treating cancer and promoting wound healing |
| JP2019537555A (ja) | 2016-09-28 | 2019-12-26 | ジェノセア バイオサイエンシーズ， インコーポレイテッド | ヘルペスを処置するための方法および組成物 |
| EP3519430A1 (en) * | 2016-09-29 | 2019-08-07 | Ipsen Biopharm Limited | Hybrid neurotoxins |
| EP3973253A4 (en) * | 2019-05-20 | 2022-08-10 | Siemens Healthcare Diagnostics, Inc. | PROCEDURE FOR DETECTING ABERRANTIC RESULTS DUE TO INCOMPLETE DELIVERY OF A POLYHAPTEN REAGENT IN IMMUNOASSAYS |
| CA3144183A1 (en) | 2019-07-03 | 2021-01-07 | Intervet International B.V. | Conjugated deoxynivalenol to protect against mycotoxicosis |
| US12343375B2 (en) | 2021-02-09 | 2025-07-01 | University Of Louisville Research Foundation, Inc. | Spray dried formulation of a cholera toxin B subunit variant |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5171568A (en) | 1984-04-06 | 1992-12-15 | Chiron Corporation | Recombinant herpes simplex gb-gd vaccine |
| US4883761A (en) | 1986-03-25 | 1989-11-28 | The United States Of America As Represented By The Department Of Health And Human Services | Pertussis toxin gene: cloning and expression of protective antigen |
| JP2661044B2 (ja) | 1986-06-17 | 1997-10-08 | カイロン コーポレイション | 肝炎δの診断薬およびワクチン |
| EP0318216B2 (en) | 1987-11-18 | 2001-08-29 | Chiron Corporation | NANBV diagnostics |
| KR0185373B1 (ko) | 1989-03-17 | 1999-05-01 | 로버트 피. 블랙버언 | Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용 |
| CA2017157C (en) | 1989-05-18 | 2003-07-29 | Michael Houghton | Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
| US5876727A (en) | 1995-03-31 | 1999-03-02 | Immulogic Pharmaceutical Corporation | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| US5840307A (en) * | 1995-03-31 | 1998-11-24 | Immulogic Pharmacuetical Corp. | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation |
| US20020032316A1 (en) | 1995-03-31 | 2002-03-14 | Cantab Pharmaceuticals Research Limited | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| FR2768747B1 (fr) | 1997-09-19 | 2000-12-01 | Pasteur Institut | Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes |
| CN1231586C (zh) * | 2003-04-15 | 2005-12-14 | 中国科学院微生物研究所 | 一种多形汉逊酵母表达重组霍乱毒素b亚单位基因及其应用 |
| GB0325494D0 (en) * | 2003-10-31 | 2003-12-03 | Sbl Vaccin Ab | Expression system |
-
2010
- 2010-03-09 CA CA2754592A patent/CA2754592A1/en not_active Abandoned
- 2010-03-09 MX MX2011009359A patent/MX2011009359A/es not_active Application Discontinuation
- 2010-03-09 US US13/255,262 patent/US20120100171A1/en not_active Abandoned
- 2010-03-09 RU RU2011140858/15A patent/RU2011140858A/ru not_active Application Discontinuation
- 2010-03-09 KR KR1020117023547A patent/KR20120022760A/ko not_active Withdrawn
- 2010-03-09 EP EP10706688A patent/EP2405943A2/en not_active Withdrawn
- 2010-03-09 JP JP2011553432A patent/JP2012519724A/ja active Pending
- 2010-03-09 CN CN2010800175877A patent/CN102427828A/zh active Pending
- 2010-03-09 WO PCT/EP2010/052997 patent/WO2010103017A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012519724A5 (enExample) | ||
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| JP2012126742A5 (enExample) | ||
| ES2563646T3 (es) | Composiciones y métodos relacionados con variantes de la proteína A (SpA) | |
| JP2008530245A5 (enExample) | ||
| JP2012507294A5 (enExample) | ||
| JP2013518052A5 (enExample) | ||
| HRP20161608T1 (hr) | Modificirani tuberkulozni antigeni | |
| JP2017048194A5 (enExample) | ||
| JP2013172734A5 (enExample) | ||
| JP2016222689A5 (ja) | 合成ペプチド及び乾燥粉末薬剤輸送システム | |
| JP2011250797A5 (enExample) | ||
| RU2017104529A (ru) | Композиции neisseria meningitidis и способы их применения | |
| WO2014018858A3 (en) | Multimeric fusion protein vaccine and immunotherapeutic | |
| JP2010011868A5 (enExample) | ||
| JP2013517783A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| EA201391240A1 (ru) | Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza | |
| MX2011011132A (es) | Peptido auxiliar del antigeno del cancer. | |
| MX2019003682A (es) | Antigenos de consenso del virus sincitial respiratorio humano, constructos de acido nucleico y vacunas hechas de estos, y metodos para utilizarlas. | |
| JP2011528896A5 (enExample) | ||
| JP2011530309A5 (enExample) | ||
| RU2015141214A (ru) | Вакцины против Chlamydia sp. | |
| JP2016514713A5 (enExample) | ||
| JP2013510169A5 (enExample) |